Literature DB >> 2159422

Specific receptors for endothelin-3 in cultured bovine endothelial cells and its cellular mechanism of action.

T Emori1, Y Hirata, F Marumo.   

Abstract

Among three endothelin (ET) isopeptides, ET-3 shows the most potent initial depressor response through the endothelium-dependent mechanism. We studied the presence of specific binding sites for ET-3 in cultured bovine endothelial cells (EC) and its cellular mechanism of action. Binding studies revealed the presence of two distinct subclasses of ET-3 receptors with high and low affinities. ET-3 dose-dependently (10(-10)-10(-7) M) increased both intracellular Ca2+ levels ([Ca2+]i) and inositol trisphosphate (IP3) formation. The ET-3-induced increase in [Ca2+]i was not affected by either removal of extracellular Ca2+ or Ca2(+)-channel blockers. These data suggest that ET-3 induces phosphoinositide breakdown and increase in [Ca2+]i in ECs, possibly resulting from intracellular Ca2+ mobilization, thereby leading to vasodilatation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2159422     DOI: 10.1016/0014-5793(90)81388-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

1.  Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells.

Authors:  Y Hirata; T Emori; S Eguchi; K Kanno; T Imai; K Ohta; F Marumo
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

Review 2.  Endothelins. A potential target for pharmacological intervention in diseases of the elderly.

Authors:  H Lévesque; N Moore; N Cailleux; V Richard; C Thuillez; H Courtois
Journal:  Drugs Aging       Date:  1994-03       Impact factor: 3.923

3.  Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anaesthetized rat.

Authors:  J P Cristol; T D Warner; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

4.  Incomplete inhibition of the pressor effects of endothelin-1 and related peptides in the anaesthetized rat with BQ-123 provides evidence for more than one vasoconstrictor receptor.

Authors:  L McMurdo; R Corder; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

5.  Presence of a phosphoramidon-sensitive endothelin-converting enzyme which converts big-endothelin-1, but not big-endothelin-3, in the rat vas deferens.

Authors:  S Télémaque; P D'Orléans-Juste
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000

6.  Different pharmacological profiles of big-endothelin-3 and big-endothelin-1 in vivo and in vitro.

Authors:  P D'Orléans-Juste; S Télémaque; A Claing
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

7.  Differential effects of BQ-123 against endothelin-1 and endothelin-3 on the rat vas deferens: evidence for an atypical endothelin receptor.

Authors:  A Eglezos; P Cucchi; R Patacchini; L Quartara; C A Maggi; J Mizrahi
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

8.  Mediation of endothelin-1-induced inhibition of platelet aggregation via the ETB receptor.

Authors:  L McMurdo; P S Lidbury; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

9.  Endothelin ETA and ETB receptors mediate vascular smooth muscle contraction.

Authors:  M J Sumner; T R Cannon; J W Mundin; D G White; I S Watts
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

10.  Endothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet-activating factor and thromboxane A2.

Authors:  J G Filep; A Fournier; E Földes-Filep
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.